Matches in SemOpenAlex for { <https://semopenalex.org/work/W2330762934> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2330762934 endingPage "83" @default.
- W2330762934 startingPage "4179" @default.
- W2330762934 abstract "A phase II trial was undertaken to test the activity and toxicity of carboplatin (300 mg/m2, i.v. day 1) + epirubicin (75 mg/m2, i.v. day 1) + VP-16 (100 mg/m2, i.v. days 1 to 3) + lenograstim (5 mcg/kg, s.c. days 6 to 15) administered every 3 weeks for 4 cycles and subsequent chest irradiation (50 Gy) + daily carboplatin (25 mg/m2) in the first-line treatment of adults affected by limited small cell lung cancer (SCLC).A single-stage phase II design was used; the complete response (CR) rate after chest radiotherapy was the primary end-point. Twenty-three CRs were required out of 38 patients to consider the treatment worthy of further study. Prophylactic cranial irradiation (PCI) was planned in case of CR. Patients aged < or = 70 were eligible if they had limited SCLC, a performance status not worse than 2 by the ECOG scale and no prior chemotherapy or radiotherapy.From January 1995 to April 1999, 33 patients were enrolled; the median age was 60 years. All the patients started chemotherapy; 23 patients received chest irradiation and concurrent daily carboplatin; 11 patients also received PCI. Toxicity was generally mild. Sixteen CRs (48.5%, 95% CI: 30.8-66.5) were recorded; the objective response rate was 72.7% (95% CI: 54.5-86.7). The median time-to-progression was 7.9 months (95% CI: 6.5-10.4). The median-survival was 10.7 months (95% CI: 9.2-16.1).Induction chemotherapy with carboplatin + epirubicin + VP-16 followed by chest irradiation plus concurrent daily carboplatin is well-tolerated but not sufficiently active to warrant further study in the treatment of patients with limited SCLC." @default.
- W2330762934 created "2016-06-24" @default.
- W2330762934 creator A5001495249 @default.
- W2330762934 creator A5005510452 @default.
- W2330762934 creator A5013942140 @default.
- W2330762934 creator A5015740152 @default.
- W2330762934 creator A5022553664 @default.
- W2330762934 creator A5029040724 @default.
- W2330762934 creator A5029922900 @default.
- W2330762934 creator A5032078755 @default.
- W2330762934 creator A5038044240 @default.
- W2330762934 creator A5045384053 @default.
- W2330762934 creator A5059187148 @default.
- W2330762934 creator A5066786694 @default.
- W2330762934 creator A5072545598 @default.
- W2330762934 creator A5075990178 @default.
- W2330762934 date "2002-03-26" @default.
- W2330762934 modified "2023-10-18" @default.
- W2330762934 title "Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study." @default.
- W2330762934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11911315" @default.
- W2330762934 hasPublicationYear "2002" @default.
- W2330762934 type Work @default.
- W2330762934 sameAs 2330762934 @default.
- W2330762934 citedByCount "1" @default.
- W2330762934 crossrefType "journal-article" @default.
- W2330762934 hasAuthorship W2330762934A5001495249 @default.
- W2330762934 hasAuthorship W2330762934A5005510452 @default.
- W2330762934 hasAuthorship W2330762934A5013942140 @default.
- W2330762934 hasAuthorship W2330762934A5015740152 @default.
- W2330762934 hasAuthorship W2330762934A5022553664 @default.
- W2330762934 hasAuthorship W2330762934A5029040724 @default.
- W2330762934 hasAuthorship W2330762934A5029922900 @default.
- W2330762934 hasAuthorship W2330762934A5032078755 @default.
- W2330762934 hasAuthorship W2330762934A5038044240 @default.
- W2330762934 hasAuthorship W2330762934A5045384053 @default.
- W2330762934 hasAuthorship W2330762934A5059187148 @default.
- W2330762934 hasAuthorship W2330762934A5066786694 @default.
- W2330762934 hasAuthorship W2330762934A5072545598 @default.
- W2330762934 hasAuthorship W2330762934A5075990178 @default.
- W2330762934 hasConcept C126322002 @default.
- W2330762934 hasConcept C126894567 @default.
- W2330762934 hasConcept C141071460 @default.
- W2330762934 hasConcept C203092338 @default.
- W2330762934 hasConcept C2776256026 @default.
- W2330762934 hasConcept C2776694085 @default.
- W2330762934 hasConcept C2776755627 @default.
- W2330762934 hasConcept C2778239845 @default.
- W2330762934 hasConcept C2778424827 @default.
- W2330762934 hasConcept C2779562246 @default.
- W2330762934 hasConcept C2780835546 @default.
- W2330762934 hasConcept C2781451048 @default.
- W2330762934 hasConcept C31760486 @default.
- W2330762934 hasConcept C45393284 @default.
- W2330762934 hasConcept C500558357 @default.
- W2330762934 hasConcept C509974204 @default.
- W2330762934 hasConcept C535046627 @default.
- W2330762934 hasConcept C71924100 @default.
- W2330762934 hasConcept C90924648 @default.
- W2330762934 hasConceptScore W2330762934C126322002 @default.
- W2330762934 hasConceptScore W2330762934C126894567 @default.
- W2330762934 hasConceptScore W2330762934C141071460 @default.
- W2330762934 hasConceptScore W2330762934C203092338 @default.
- W2330762934 hasConceptScore W2330762934C2776256026 @default.
- W2330762934 hasConceptScore W2330762934C2776694085 @default.
- W2330762934 hasConceptScore W2330762934C2776755627 @default.
- W2330762934 hasConceptScore W2330762934C2778239845 @default.
- W2330762934 hasConceptScore W2330762934C2778424827 @default.
- W2330762934 hasConceptScore W2330762934C2779562246 @default.
- W2330762934 hasConceptScore W2330762934C2780835546 @default.
- W2330762934 hasConceptScore W2330762934C2781451048 @default.
- W2330762934 hasConceptScore W2330762934C31760486 @default.
- W2330762934 hasConceptScore W2330762934C45393284 @default.
- W2330762934 hasConceptScore W2330762934C500558357 @default.
- W2330762934 hasConceptScore W2330762934C509974204 @default.
- W2330762934 hasConceptScore W2330762934C535046627 @default.
- W2330762934 hasConceptScore W2330762934C71924100 @default.
- W2330762934 hasConceptScore W2330762934C90924648 @default.
- W2330762934 hasIssue "6A" @default.
- W2330762934 hasLocation W23307629341 @default.
- W2330762934 hasOpenAccess W2330762934 @default.
- W2330762934 hasPrimaryLocation W23307629341 @default.
- W2330762934 hasRelatedWork W2070310013 @default.
- W2330762934 hasRelatedWork W2071189140 @default.
- W2330762934 hasRelatedWork W2262589784 @default.
- W2330762934 hasRelatedWork W2330762934 @default.
- W2330762934 hasRelatedWork W2359366932 @default.
- W2330762934 hasRelatedWork W2590321086 @default.
- W2330762934 hasRelatedWork W2755166669 @default.
- W2330762934 hasRelatedWork W2990302167 @default.
- W2330762934 hasRelatedWork W3031350720 @default.
- W2330762934 hasRelatedWork W2428985727 @default.
- W2330762934 hasVolume "21" @default.
- W2330762934 isParatext "false" @default.
- W2330762934 isRetracted "false" @default.
- W2330762934 magId "2330762934" @default.
- W2330762934 workType "article" @default.